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Abstract
Despite the increasing use of computed tomography pulmonary angiography to evaluate for pulmonary 
embolism (PE), ventilation/perfusion (V/Q) scintigraphy is still a fairly common examination. A rare 
finding on V/Q scintigraphy is whole‑lung mismatched perfusion defect. Although this finding can 
occur with PE, it has an important, limited differential diagnosis. In this pictorial essay, we describe 
different causes of acquired whole‑lung mismatched perfusion defect.
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Introduction
Pulmonary ventilation/perfusion (V/Q) 
scintigraphy is often performed to evaluate 
for pulmonary embolism (PE) and to provide 
global and semi‑quantitative data about 
pulmonary function. Many disease processes 
affect pulmonary ventilation and perfusion 
and may result in abnormal findings on 
pulmonary V/Q scintigraphy. One particularly 
striking finding is absent or severely decreased 
unilateral whole‑lung perfusion, which is seen 
on approximately 2% of V/Q scans and can 
occur with normal or abnormal ventilation.[1] 
However, only about 2% of pulmonary emboli 
present as a whole‑lung mismatched perfusion 
defect, so alternative diagnoses should be 
considered. The goal of this pictorial essay 
is to review the differential diagnosis for 
acquired whole‑lung mismatched perfusion 
defect on V/Q scintigraphy. These illustrative 
cases include the diagnoses of large PE, 
fibrosing mediastinitis, hilar malignant tumor, 
pulmonary vein stenosis, and pulmonary 
fibrosis.
Pulmonary embolism
PE, which is part of the spectrum of venous 
thromboembolic disease, is caused by a 
venous blood clot that typically forms 
in the lower extremities, migrates into a 
pulmonary artery, and limits the flow of 
deoxygenated blood into the lungs. A large 
embolus that obstructs all flow in the 
pulmonary artery of one lung may lead to 
whole‑lung perfusion defect with preserved 
ventilation [Figure 1].
PE is common and may become 
life‑threatening if not diagnosed and treated 
quickly.[2] Clinically, PE may present 
with shortness of breath, chest pain, or 
tachycardia; however, patients are often 
asymptomatic. PE can occur in all age 
groups. Factors that increase its likelihood 
include prolonged immobilization, recent 
surgery, hypercoagulable state, cancer, 
trauma, and pregnancy. Although computed 
tomography pulmonary angiography (CTPA) 
has become the radiologic diagnostic test of 
choice for PE, V/Q scintigraphy is a popular 
alternative test if CT is contraindicated. 
According to the modified criteria of 
prospective investigation of PE diagnosis II, 
findings on V/Q scan are considered highly 
suggestive of PE if two or more segments 
show perfusion scan–chest radiograph 
mismatch.[3] Although it is rare for a large PE 
to obstruct flow to an entire lung unilaterally, 
it must always be considered in the case of a 
whole‑lung V/Q mismatch [Figure 1].
In general, PE is initially treated with 
anticoagulation, but more invasive 
approaches, such as percutaneous 
thrombectomy, can be considered if the 
patient’s condition is sufficiently critical.
Fibrosing mediastinitis
Fibrosing mediastinitis is a benign, 
progressive proliferation of acellular 
collagen and fibrous tissue throughout the 
mediastinum.[4] As the tissue progresses, it This is an open access journal, and articles are 
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may eventually encase and compress the normal structures 
of the mediastinum, including the pulmonary arteries and 
veins. Asymmetric compression of the pulmonary artery, 
veins, or both may lead to whole‑lung perfusion defect 
with preserved ventilation [Figure 2].
Fibrosing mediastinitis typically occurs in patients over 
a wide range of ages with a mean age of approximately 
40 years, and the most common causes of fibrosing 
mediastinitis are granulomatous infections, especially those 
caused by Histoplasma capsulatum and Mycobacterium 
tuberculosis. Two types of fibrosing mediastinitis – focal 
and diffuse – have been described. The focal type is 
more common and is generally localized to one region 
of the mediastinum. The less common diffuse type is 
more proliferative. Clinical presentation depends on the 
affected mediastinal structures. Reported symptoms and 
signs include dyspnea and hemoptysis. The clinical course 
may be highly variable, and the overall mortality rate is 
reportedly as high as 30%.[4]
If fibrosing mediastinitis is suggested, the diagnosis 
is typically confirmed with CT or magnetic resonance 
imaging. On CT, fibrosing mediastinitis appears as a 
calcified soft‑tissue mass that is usually near the hilum of 
the lung. The characteristics of fibrosing mediastinitis may 
be difficult to identify on magnetic resonance imaging 
because of its poor sensitivity for detecting calcium, but 
fibrosing mediastinitis generally manifests as abnormally 
enhancing tissue with heterogeneous T1‑ and T2‑weighted 
signal near the hilum of the lung [Figure 2d and e].
Treatment depends on the degree of fibrosis and 
the structures involved. Mild cases may respond to 
corticosteroid or antifungal therapy. Severe cases may 
require vascular or airway stenting. Surgical resection 
may be considered but is generally associated with 
substantially greater morbidity and mortality rates.
Hilar malignant tumor
Perihilar tumor is an important consideration in the 
differential diagnosis of whole‑lung mismatched perfusion 
defect.[5] The most common tumors are lung carcinoma and 
metastatic hilar adenopathy; lymphoma is less likely. If 
concomitant hypoxia is present, these masses may decrease 
ipsilateral lung perfusion by direct vascular invasion or 
reflex vasoconstriction [Figure 3].
Lung cancer is the most commonly diagnosed cancer 
worldwide, and as many as 90% of cases are associated 
with tobacco use.[6] Lung cancer typically affects patients 
older than 50 years and is often clinically asymptomatic 
until it becomes advanced. Patients with advanced lung 
cancer may have postobstructive pneumonia, hemoptysis, 
cough, and dyspnea.
Perihilar tumor is most commonly diagnosed on the basis of 
findings on chest CT, which typically presents as a spiculated 
parenchymal opacity [Figure 3d]. Confirmation requires 
percutaneous or endobronchial biopsy. When the diagnosis 
is established, staging is typically performed with positron 
emission tomography with CT. Prognosis depends on the 
disease stage and the specific histologic type of cancer.
Figure 1: Large right pulmonary embolism. (a and b), Ventilation (a) and perfusion (b) images obtained with ventilation/perfusion scintigraphy: Mildly 
heterogeneous ventilation without perfusion to the right lung. (c) Chest radiograph: Mild interstitial thickening. (d) Computed tomography pulmonary 
angiogram: Right pulmonary artery occlusion secondary to pulmonary embolus (*) and decreased perfusion throughout right lung. (e and f), Conventional 
pulmonary angiograms: right pulmonary artery occlusion (e) and hypoperfusion of the lingula (f). LT: Left; POST: Posterior; RT: Right
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In our experience, perihilar tumors more often cause 
whole‑lung matched perfusion defects than mismatched 
defects on V/Q scans. By the time a tumor is large 
enough to obstruct the central pulmonary vasculature and 
the perfusion of an entire lung; it usually has obstructed 
most of the central airways. Indeed, we have found that 
whole‑lung mismatched perfusion defects are more often 
secondary to fibrosing mediastinitis and pulmonary vein 
stenosis than cancer.
Pulmonary vein stenosis
Pulmonary vein stenosis is the narrowing of a pulmonary 
vein and typically occurs at its insertion site to the 
left atrium. Most commonly, pulmonary vein stenosis 
develops as a complication of radiofrequency catheter 
ablation to treat atrial fibrillation, but it can also develop 
after lung transplant and, much less often, in patients 
with congenital heart disease.[7] Among radiofrequency 
ablation‑related cases, the incidence of pulmonary vein 
stenosis depends on the radiofrequency technique and 
operator experience. A single stenotic pulmonary vein is 
frequently asymptomatic; however, a whole‑lung perfusion 
defect may develop if both veins that drain the same lung 
are stenotic and impede pulmonary circulation [Figure 4]. 
Symptoms associated with pulmonary vein stenosis are 
typically vague, including shortness of breath, cough, 
hemoptysis, and pleuritic chest pain. Symptoms can easily 
mimic those of PE.
Pulmonary vein stenosis is most commonly diagnosed with 
electrocardiography‑gated CT angiography. Mild cases 
demonstrate narrowing of the pulmonary vein ostium and 
occasionally soft‑tissue thickening around the ostium. As 
the stenosis becomes more severe, there may be decreased 
contrast opacification of the blood pool in the affected vein, 
eventually leading to venous thrombosis and/or chronic 
occlusion. A small percentage of pulmonary vein stenoses 
Figure 2: Fibrosing mediastinitis. (a and b), Ventilation‑perfusion scans: Severely decreased ventilation (a) and no perfusion (b) to right lung. (c) Chest radiograph: 
right lung decreased volume, surgical clips, nodules, band‑like opacities, and cavities (arrowheads). (d and e), T1‑weighted postcontrast (gadofosveset) 
magnetic resonance images. Axial fat‑saturated image (d): Narrowing and distal occlusion of the right pulmonary artery (arrowhead). Coronal motion‑corrected 
subtraction image (e): Abnormally enhancing soft tissue encasing carina and right mainstem bronchus (arrows). LT: Left; POST: Posterior; RT: Right
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Figure 3: Right hilar malignant tumor. (a) Ventilation image showing 
a small ventilation defect in the right hilum (arrowhead); ventilation is 
otherwise preserved. (b) Perfusion image showing severely decreased 
perfusion to the entire right lung. (c) Chest radiograph showing a right 
hilar mass (arrowheads) and a round parenchymal nodule in the right 
midlung (arrow). (d) Axial contrast‑enhanced computed tomography image 
showing a right hilar mass (arrowhead). LT indicates left; POST, posterior; 
RT, right
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will progress, and a similar percentage will spontaneously 
improve.
When clinically significant, pulmonary vein stenosis can 
be treated with balloon angioplasty and stent placement. 
As many as 50% of stented veins develop restenosis. The 
decision to treat asymptomatic, high‑grade pulmonary vein 
stenosis is controversial.[8]
Pulmonary fibrosis
Parenchymal lung disease, when sufficiently advanced, 
often has associated perfusion defects on pulmonary 
scintigraphy. These defects are often symmetric, but a 
whole‑lung perfusion defect may result if the lungs have 
substantially different degrees of disease involvement. 
This is particularly evident in patients with unilateral lung 
transplant [Figure 5]. The transplanted lung may perfuse 
normally, whereas the fibrotic native lung may have little 
to no measurable perfusion.[5]
Pulmonary fibrosis can be diagnosed with chest radiography, 
but chest CT is more typically used. Modern CT scanners 
and acquisition protocols typically preclude the need for 
high‑resolution reformatted images of the chest, but these 
can still be obtained if clinically necessary. A careful 
review of medical history, particularly whether the patient 
is a lung transplant recipient, is critical to the evaluation 
of a whole‑lung perfusion defect in a patient with a 
history of pulmonary fibrosis. Knowing the side of the 
transplant is also important because vascular compromise 
of the transplanted lung may cause paradoxical whole‑lung 
perfusion defect on the side of the transplant.
Figure 4: Pulmonary vein stenoses. (a and b), Ventilation‑perfusion scans: preserved ventilation (a) and decreased perfusion (b) of the left lung and the 
superior segment of the right lower lobe (arrowhead). (c) Chest radiograph: Pulmonary edema. (d‑f) Axial electrocardiography‑gated contrast‑enhanced 
cardiac computed tomography angiograms: (d) mild/moderate right superior pulmonary vein ostial narrowing (arrowhead) and abnormal tissue surrounding 
ostium (*); (e) moderate/severe right inferior pulmonary vein ostial stenosis (arrowhead) and surrounding soft tissue (*); (f) left superior pulmonary vein 
ostial stenosis and poor left superior pulmonary vein opacification (arrows). Note: image (d) is the same as image (f). LT: Left; POST: Posterior; RT: Right
a b c
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Figure 5: Pulmonary fibrosis with left lung transplant. (a) Ventilation image showing a small right lung and symmetrical ventilation. (b) Perfusion image 
showing no perfusion to the native right lung. (c) Chest radiograph showing fibrosis throughout the native right lung and a clear transplanted left lung. 
LT indicates left; POST: Posterior; RT: Right
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Symptoms related to pulmonary fibrosis typically include 
dyspnea with exertion, which is often long‑standing. 
Nonproductive cough is frequently reported. Signs of poor 
oxygenation that may be present include clubbed fingers 
and the need for oxygen at rest.
The treatment of pulmonary fibrosis is mainly supportive; 
however, the treatment of the primary condition may be 
beneficial if fibrosis is secondary to another disease. Many 
cases, however, are idiopathic and typically progress. 
Medical therapies often provide little benefit, and definitive 
treatment usually requires lung transplant.[9]
Other causes
In addition to these described causes, whole‑lung 
mismatched perfusion defects secondary to aortic dissection 
have been reported.[10] This pictorial essay focused entirely 
on acquired causes of mismatched perfusion defect. 
Congenital causes, such as congenital stenosis or atresia of 
the pulmonary arteries or veins, may have similar findings 
but are exceedingly rare compared with acquired causes.
Conclusion
With advancements in the availability and quality of 
CTPA, the use of V/Q scintigraphy to evaluate for PE 
has decreased. However, V/Q scintigraphy can still be 
used to evaluate chronic pulmonary disease, pulmonary 
hypertension, and PE in patients who are unable to 
undergo CTPA. It is also used in presurgical planning for 
lung resection and transplant. Accordingly, identification 
and understanding of specific V/Q scan patterns remain 
important because these examinations continue to be used 
in patient care. Whole‑lung mismatched V/Q defects are 
uncommon but are still encountered in clinical practice, 
and the ability to identify common causes of this finding 
is important. In almost all cases, the patient medical 
history and appropriate cross‑sectional imaging will 
allow for an accurate diagnosis and guide appropriate 
treatment.
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